Literature DB >> 8170552

Transient neurologic and ocular manifestations in primary thrombocythemia.

J J Michiels1, P J Koudstaal, A H Mulder, H H van Vliet.   

Abstract

We report the presenting neurologic and visual symptoms in 17 patients with primary thrombocythemia. Poorly localizing symptoms occurred in 14 patients: transient unsteadiness in 13, dysarthria in eight, and scintillating scotomata in four. Nine patients had focal symptoms: transient monocular blindness in two patients, transient mono- or hemiparesis in six, and both of these in one patient. The attacks all had a sudden onset, occurred sequentially rather than simultaneously, lasted for a few seconds to several minutes, and were usually associated with a dull or pulsatile headache. A causal platelet-mediated arterial thrombosis was evident in 15 patients. There were no recurrences of thrombotic or ischemic events during long-term treatment of 12 patients with aspirin and during cytostatic reduction of platelet count to normal in seven patients. We conclude that low-dose aspirin and reduction of platelet count to normal are effective, but coumarin is ineffective, in the treatment and prevention of arterial thrombosis in thrombocythemia.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8170552     DOI: 10.1212/wnl.43.6.1107

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  8 in total

1.  Neurological disorders in essential thrombocythemia.

Authors:  Segolene Billot; Eirini G Kouroupi; Johan Le Guilloux; Bruno Cassinat; Caroline Jardin; Thierry Laperche; Pierre Fenaux; Antoine F Carpentier; Jean-Jacques Kiladjian
Journal:  Haematologica       Date:  2011-09-20       Impact factor: 9.941

2.  Familial essential thrombocythemia: clinical characteristics of 11 cases in one family.

Authors:  R J Schlemper; A P van der Maas; J C Eikenboom
Journal:  Ann Hematol       Date:  1994-03       Impact factor: 3.673

Review 3.  Primary thrombocythemia: diagnosis, clinical manifestations and management.

Authors:  P J van Genderen; J J Michiels
Journal:  Ann Hematol       Date:  1993-08       Impact factor: 3.673

4.  Essential thrombocythemia, unremarkable cause of atypical chest pain with simple yet effective treatment: a case report.

Authors:  Kevin J Patel; Amit Banga; Shahibzada U Latif
Journal:  Cases J       Date:  2009-09-11

5.  Age-Related Macular Degeneration in Patients With Chronic Myeloproliferative Neoplasms.

Authors:  Marie Bak; Torben Lykke Sørensen; Esben Meulengracht Flachs; Ann-Dorthe Zwisler; Knud Juel; Henrik Frederiksen; Hans Carl Hasselbalch
Journal:  JAMA Ophthalmol       Date:  2017-08-01       Impact factor: 7.389

6.  Essential thrombocytemia and ischemic stroke: report of six cases.

Authors:  L Casto; M Camerlingo; G Finazzi; B Censori; T Barbui; A Mamoli
Journal:  Ital J Neurol Sci       Date:  1994-10

7.  Consistent up-regulation of Stat3 Independently of Jak2 mutations in a new murine model of essential thrombocythemia.

Authors:  Vitalyi Senyuk; Ciro Roberto Rinaldi; Donglan Li; Francesca Cattaneo; Aleksandra Stojanovic; Fabrizio Pane; Xiaoping Du; Nadim Mahmud; Jerome Dickstein; Giuseppina Nucifora
Journal:  Cancer Res       Date:  2009-01-01       Impact factor: 12.701

Review 8.  Headache in essential thrombocythaemia.

Authors:  R Frewin; A Dowson
Journal:  Int J Clin Pract       Date:  2012-08-14       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.